Table 2.
Strain | Intervention | TF | Fibrinogen | PAI-1 | Il-6 |
---|---|---|---|---|---|
(pg/mL) | (mg/mL) | (pg/mL) | (pg/mL) | ||
WT | Sham | 22.9±0.99 | 3.08±0.13 | 47.6±26.3 | 58.6±14.1 |
CLP | 112.6±20.7*** | 3.53±0.31 | 39,001±10828** | 142,890±24442**** | |
TLR7−/− | Sham | 23.4±0 | 2.91±0.12 | 28.1±12.29 | 118±4.25 |
CLP | 24.7±5.7Δ | 4.41±0.62* | 23,571±7563** | 12,249±3391**/ΔΔΔ | |
TLR2−/− | Sham | 23.4±0 | 3.05±0.18 | 9.38±0 | 15.6±0 |
CLP | 39.3±5.97* | 4.04±0.23** | 52,027±12927** | 4,734±3239ΔΔ | |
MyD88−/− | Sham | 23.4±25 | 2.22±0.27 | 9.38±0 | 51.3±16.6 |
CLP | 25±4.52Δ | 4.54±0.39*** | 27,206±8099* | 6,814±2009*/ΔΔΔ | |
Trif−/− | Sham | 23.4±0 | 2.72±0.12 | 9.38±0 | 16.7±5.95 |
CLP | 68.7±35.3 | 5.88±0.45*** | 46,040±16549* | 64,686±32823 | |
TLR3−/− | Sham | 23.4±0 | 2.93±0.15 | 9.38±0 | 7.69±3.24 |
CLP | 92.8±33.8 | 2.36±0.47 | 26,114±6338** | 39,778±16656 | |
TLR4−/− | Sham | 23.4±0 | 3.26±0.21 | 9.38±0 | 66.4±23.2 |
CLP | 113.9±30.9* | 2.12±0.60 | 44,391±16723* | 109,463±34771** |
* or # represents significant difference between sham and CLP mice within the same strain.
represents significant difference between WT CLP and TLR−/− CLP mice.
P = 0.05
P < 0.05
P < 0.01
P < 0.001
P < 0.0001
WT (Sham= 18–23, CLP= 26–33), TLR3−/− (Sham= 5–6, CLP= 5–6), TLR4−/− (Sham= 4–5, CLP= 4–5), TLR2−/− (Sham= 6, CLP= 5–6), TLR7−/− (Sham= 7–11, CLP= 7–12), MyD88−/− (Sham= 7–8, CLP= 8–12), and Trif−/− (Sham= 4, CLP= 6)
CLP = cecal ligation and puncture, MCF = maximum clot firmness, TLR = Toll-like receptor.